CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 409 filers reported holding CRISPR THERAPEUTICS AG in Q3 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $998,489 | -6.5% | 21,998 | +15.6% | 0.02% | 0.0% |
| Q2 2023 | $1,067,951 | +31.6% | 19,023 | +6.0% | 0.02% | +23.5% |
| Q1 2023 | $811,607 | +6.5% | 17,944 | -4.3% | 0.02% | 0.0% |
| Q4 2022 | $762,025 | -41.0% | 18,746 | -5.2% | 0.02% | -43.3% |
| Q3 2022 | $1,292,000 | +16.7% | 19,777 | +8.6% | 0.03% | +25.0% |
| Q2 2022 | $1,107,000 | +3.5% | 18,203 | +6.8% | 0.02% | +26.3% |
| Q1 2022 | $1,070,000 | -26.9% | 17,041 | -11.7% | 0.02% | -26.9% |
| Q4 2021 | $1,463,000 | -36.4% | 19,297 | -6.1% | 0.03% | -39.5% |
| Q3 2021 | $2,300,000 | -17.3% | 20,546 | +19.6% | 0.04% | -14.0% |
| Q2 2021 | $2,781,000 | +116.4% | 17,179 | +62.9% | 0.05% | +92.3% |
| Q1 2021 | $1,285,000 | -7.6% | 10,544 | +16.0% | 0.03% | -10.3% |
| Q4 2020 | $1,391,000 | +77.9% | 9,088 | -2.8% | 0.03% | +45.0% |
| Q3 2020 | $782,000 | +6.5% | 9,351 | -6.4% | 0.02% | +5.3% |
| Q2 2020 | $734,000 | +59.6% | 9,990 | -7.8% | 0.02% | +35.7% |
| Q1 2020 | $460,000 | +88.5% | 10,840 | +171.1% | 0.01% | +133.3% |
| Q4 2019 | $244,000 | -5.8% | 3,999 | -44.9% | 0.01% | -14.3% |
| Q1 2019 | $259,000 | -5.8% | 7,254 | +17.0% | 0.01% | 0.0% |
| Q3 2018 | $275,000 | – | 6,202 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $27,989,046 | 33.20% |
| Gilfoyle Management LLC | 100 | $4,842 | 15.90% |
| NEA Management Company, LLC | 1,587,854 | $89,142,124 | 6.80% |
| ARK Investment Management | 7,338,447 | $411,980,394 | 2.73% |
| Nikko Asset Management Americas, Inc. | 3,533,357 | $198,327,328 | 2.09% |
| Del-Sette Capital Management, LLC | 33,661 | $1,889,729 | 1.79% |
| Ikarian Capital, LLC | 200,000 | $11,228,000 | 1.79% |
| Ikarian Capital, LLC | 200,000 | $11,228,000 | 1.79% |
| Merlin Capital, Inc | 8,802 | $494,144 | 1.67% |
| Green Alpha Advisors, LLC | 34,373 | $1,929,700 | 1.27% |